Loading clinical trials...
Loading clinical trials...
Pilot Study of Imatinib Discontinuation in Patients With Chronic Myeloid Leukemia With Deep Molecular Response - Evaluation of Pioglitazone in Treatment-free Remission (EDI-PIO)
Conditions
Interventions
Pioglitazone 30 Mg Oral Tablet
imatinib discontinuation
Locations
1
Brazil
Centro de Hematologia e Hemoterapia - Universidade Estadual de Campinas
Campinas, São Paulo, Brazil
Start Date
June 22, 2016
Primary Completion Date
February 7, 2024
Completion Date
February 7, 2024
Last Updated
March 30, 2025
Lead Sponsor
University of Campinas, Brazil
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions